Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for subcortical ischaemic vascular dementia
ISRCTN31208535Phase 2Terminated
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in subcortical vascular dementia (SVD) comparing Amlodipine with Placebo (2 arms). Primary endpoint: Change in Vascular Dementia Assessment Scale cognitive subscale score. Started Oct 2014; status: terminated.
02
Drugs
amlodipine
03
Conditions
subcortical vascular dementia (SVD)
Beyond the preview
Go deeper on ISRCTN31208535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31208535.